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ABSTRACT
Purpose: This study aimed to determine the effect of an exercise intervention on subjective 
cancer-related fatigue (CRF) and pro-inflammatory cytokine levels in breast cancer 
survivors (BCS).
Methods: BCS with greater than moderate CRF (≥ 4) were recruited and randomly assigned 
to experimental or control groups. The experimental group participated in a 12-week exercise 
adherence program (Better Life after Cancer - Energy, Strength, and Support; BLESS). 
Interleukin (IL)-6 and tumor necrosis factor-α (TNF-α) levels were determined at 3 time 
points (M1: baseline, M2: post-intervention, and M4: 6 months after intervention). Subjective 
fatigue was measured using the Korean version of the revised Piper Fatigue Scale.
Results: In this analysis of participants with physiological fatigue measures available (19 
experimental, 21 control), there were no statistically significant differences in IL-6 (F = 1.157, 
p = 0.341), TNF-α levels (F = 0.878, p = 0.436), and level of fatigue (F = 2.067, p = 0.118) between 
the 2 groups at baseline. Fatigue in the experimental group showed statistically significant 
improvement compared to the control only at M2 (p = 0.022). There was no significant 
relationship between subjective and physiological fatigue at the 3 measurement points.
Conclusion: The BLESS intervention improved CRF in BCS immediately at post-intervention, 
and this study presents clinical feasibility for the management of CRF in BCS in the early 
survivorship phase who are already experiencing fatigue.
Keywords: Breast neoplasms; Cytokines; Exercise; Fatigue
INTRODUCTION
Breast cancer (BC) is the most common cancer type among women worldwide, with 2.18 
million newly-diagnosed cases in 2018, and is a major cause of cancer-related death [1]. 
However, early detection of BC and standard treatments such as surgery, chemotherapy, 
radiation therapy, and endocrine therapy have led to an increase in long-term breast cancer 
survivors (BCS). BCS experience various side effects not only during cancer diagnosis 
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and treatment but also after completion of cancer treatment, of which fatigue is the most 
common. Cancer-related fatigue (CRF) is a distressing symptom experienced by a large 
number of BCS, which degrades quality of life (QoL), with 7% to 52% of BCS reporting severe 
fatigue [2]. Therefore, CRF is a clinical problem to be managed and improved over the long-
term; however, effective and systematic intervention strategies are still required.
Physical activity in BCS is strongly recommended, as it has been reported in a systematic 
literature review to be associated with reduction in cancer mortality [3]. Exercise has 
also been shown to be a crucial intervention in significantly lowering the fatigue of BCS, 
particularly among various fatigue interventions such as drug therapy, training and 
counseling, and complementary therapies [4-8]. Exercise not only reduces fatigue but also 
improves negative emotions such as depression, anxiety, and distress, and leads to improved 
self-esteem and QoL [9-11]. However, although the short-term effectiveness of exercise has 
been verified to improve CRF in previous studies, there is a lack of related reports on exercise 
adherence from a longitudinal perspective [4,5,8,10].
Patients who experience CRF have an increase in the levels of pro-inflammatory cytokines 
(e.g., tumor necrosis factor-α [TNF-α], interleukin [IL]-1, and IL-6) [11,12]. As physical 
activity increases, systemic levels of IL-6 increase, while TNF-α levels decrease [12]. 
Strenuous physical activity rapidly increases IL-6 levels, and the response to moderate 
intensity repeated exercise also shows a long-term increase in IL-6 levels [13,14]. IL-6 and 
TNF-α were reported to be significantly associated with self-reported fatigue [15]. These 
pro-inflammatory cytokines have been used to test the effect of physical activity in the 
management of CRF, but a consensus has not been reached. Levels of IL-6 and TNF-α were 
reported to show no significant difference following an exercise intervention [16], and no 
consistent results were found in longitudinal studies of fatigue [17].
The National Institute of Health Symptom Science Model (NIH-SSM) focuses on improving 
patient outcomes, as well as QoL, by identifying complex symptoms with biological and 
clinical data and presenting directions for therapeutic and clinical interventions [18]. CRF 
in BCS is a complex phenomenon characterized by biobehavioral symptoms, and may be 
assessed by measuring pro-inflammatory cytokines; CRF can be reduced through an exercise 
intervention, leading to improvements in QoL. Therefore, this study aimed to identify 
the effects of a 12-week exercise intervention based on the NIH-SSM on CRF and pro-
inflammatory cytokines in BCS.
METHODS
Study design
This study was based on data from the Better Life after Cancer - Energy, Strength, and 
Support (BLESS) study. BLESS is an exercise adherence intervention developed for BCS 
with greater than moderate fatigue, following a systematic theory-based approach [19]. 
Estimation of sample size was calculated according to the requirements for multivariate 
analysis of variance testing. We estimated 46 participants were needed, which was based 
on the effect size of 0.8 from a prior study [20,21]. Estimating a dropout rate of 20%, a 
total of 66 participants were assessed for eligibility and 50 BCS were randomly assigned to 
experimental (n = 24) and control (n = 26) groups (Figure 1). The mean participation rate was 
over 90%.
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Participants
Participant data were obtained from the BLESS study [21], which was conducted at a tertiary 
hospital in Seoul, Korea, between 2017 and 2018. Ethics approval was given by the Severance 
Hospital Institutional Review Board (approval number 4-2017-0164). We recruited participants 
by posting recruitment announcements in the hospital cancer center's outpatient department 
and through social network systems targeting BCS. While details on inclusion and exclusion 
criteria are described elsewhere [21], participants were female BCS between 20–69 years who 
had completed surgery and chemotherapy and were within 5 years of diagnosis. Fatigue was 
screened on a 0–10 scale and those with greater than moderate fatigue (≥ 4) were eligible. 
Written informed consent was obtained from all participants before enrollment.
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Excluded (n = 16)
• Not meeting inclusion criteria (n = 11)
• Declined to participate (n = 5)
Allocated to intervention (n = 24)
• Incomplete questionnaire data  (n = 1)
• Failure to blood test (n = 4)
Assessed for eligibility (n=66)
Allocated to usual care control group (n = 26) 
• Incomplete questionnaire data  (n = 1)
• Failure to blood test (n = 8) 
Attend to follow-up (n = 23)
 • Drop out due to death (n = 1)
 • Failure to blood test (n = 4)
Attend to follow-up (n = 25)
 • Drop out due to family illness (n = 1)
 • Failure to blood test (n = 8)
Attend to follow-up (n = 23) Attend to follow-up (n = 24) 
• Lost  to follow-up (n = 1)
• Non-response questionnaire (n = 2)
Attend to follow-up (n = 23)
 • Non-response questionnaire (n = 2)
 • Failure to blood test (n = 7)
Attend to follow-up (n = 23)     
 • Dropout due to recurrence (n = 1) 
 • Failure to blood test (n = 13)
Analyzed questionnaire (n = 19)
 • Excluded  outlier (n = 4)
Analyzed blood test (n = 12)
 • Excluded outlier (n = 4)
 • Failure to blood test (n = 7)
Analyzed questionnaire (n = 21)
 • Excluded difference enrollment (n = 2) 
Analyzed blood test (n = 6)
 • Excluded difference enrollment (n = 2)
 • Excluded outlier (n = 2)





Figure 1. CONSORT diagram indicating number of participants who completed each measurement. 
M1 = pre-intervention; M2 = post-intervention; M3 = after 1 month; M4 = after 6 months.
Intervention procedures
The BLESS exercise adherence program consisted of 8 exercise movements, specific to 
the needs of BCS, administered once a week for 12 weeks [19]. The experimental group 
participated in supervised exercise during the first 6 weeks, and then carried out the exercise 
program at home during the remaining 6 weeks. The BLESS program combined stretching 
and resistance exercise tailored to the limitations and needs of BCS with a gradual increase in 
intensity into light, moderate, and vigorous movements. Exercise video clips were provided 
to encourage adherence and promote accurate practice, and group exercise was done at every 
measurement point for the experimental group (Figure 2). The BLESS group also participated 
in small group sessions that aimed to activate social capital [21]. The control group was not 
prescribed a structured exercise program but received exercise-related handouts and offered 
the BLESS exercise at the end of the 12-week period. In order to minimize loss, during the 
follow up period after the end of the 12-week exercise program, we provided special activities 
e.g., candle making, calligraphy sessions, and other activities at follow up measurement 
points for both the experimental and the control groups. In order to test the effectiveness 
of the BLESS program, measurements were taken at 5 time points [21]: This manuscript 
focuses on the following time points: baseline (M1), post-intervention (M2; 12 weeks later), 
1 month later (M3), and at 6 months (M4) after the intervention (Figure 3). Subjective fatigue 
was measured by self-report questionnaires at all time points, and physiological fatigue was 
measured at M1, M2, and M4.
Measured parameters
Physiological fatigue
IL-6 and TNF-α levels were measured at M1, M2, and M4 using enzyme-linked 
immunosorbent assay (ELISA) kits according to the manufacturer's instructions (KOMA 
BIOTECH, Seoul, Korea). Briefly, 50 µL of plasma was loaded into wells coated with 
antibodies and incubated at room temperature for 4 hours on a microplate shaker. Wells were 
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Week 1 2 3 4 5 6 7 8 9 10 11 12
Stretching
Exercise









Supervised exercise Home-based exercise
Figure 2. BLESS exercise adherence intervention program for experimental group. 
















Figure 3. Study design for the BLESS program. 
BLESS = Better Life after cancer – Energy, Strength, and Support; E = experimental group; C = control group; M1 = 
baseline; M2 = post-intervention; M3 = after 1 month; M4 = after 6 months.
washed with the buffer provided and incubated with detection antibody at room temperature 
for 2 hours. Finally, plates were read with a spectrophotometric microplate reader at 450 nm. 
Cytokine concentrations were calculated from the standard curve and dilution factor.
Subjective fatigue
The revised Piper Fatigue Scale (R-PFS) [22] is a commonly used self-reported tool for cancer-
related studies that can measure fatigue in a multidimensional manner. CRF was measured 
using the Korean version of R-PFS (R-PFS-K) [23]. This tool contains a total of 19 items with 4 
subcategories: Behavioral/Severity (6 items), Affective Meaning (4 items), Sensory (4 items), 
and Cognitive/mood (5 items). The degree of fatigue currently experienced is assessed using 
a 0 to 10 scale; the higher the score, the more severe the fatigue. This tool previously showed 
high reliability (Cronbach's α = 0.97) [23]; in this study, Cronbach's α ranged from 0.92 to 
0.94 across the subcategories.
Demographic and clinical factors
The examined demographic factors were age, marital status, income, employment status, 
religion, economic burden, education level, and whether they had children. Clinical factors 
related to BC included cancer stage, surgery type, time since diagnosis, chemotherapy, 
radiation therapy, endocrine therapy, target therapy, and triple-negative BC status.
Statistical analysis
The collected data were analyzed using SPSS for Windows version 23.0 (IBM Corp., Chicago, 
IL, USA). The homogeneity of the experimental and control groups were tested at baseline 
using t-test or chi-square test for each factor as appropriate. The CONSORT diagram 
presented in Figure 1 depicts the number of participants who completed each measurement. 
The effect of the BLESS program on the physiological and subjective fatigue measured at 
M1, M2, M3, and M4 was tested using a repeated-measures analysis of variance (ANOVA). 
Data could not be obtained in cases of missing questionnaire data at the particular time 
point or blood sampling not being performed due to refusal or insufficient blood volume. 
The physiological data of 6 participants who had much higher than average IL-6 and TNF-α 
levels due to health-related events, such as chemotherapy or radiation therapy in the last 3 
months or undergoing periodontitis treatment, were identified as outliers and excluded from 
analysis, resulting in 40 participants. Differences in changes in the measured parameters 
were tested using a fixed effects model with a linear mixed model, which included all missing 
values  in the analysis. M1 values were considered as baseline and comparisons were made 
between time points and groups; the interaction effect between time points and groups was 
also tested. Bonferroni correction was used to adjust for multiple comparisons. Time point 
differences were tested using repeated-measures ANOVA; 2 participants were excluded from 
this analysis due to enrolling at different time points. The level of statistical significance was 
set at p < 0.05.
RESULTS
Demographic and clinical factors
A total of 40 BCS with subjective fatigue data at all 4 time points were analyzed (19 in the 
experimental group, 21 in the control) and their demographic and clinical characteristics are 
shown in Table 1. There was no significant heterogeneity between the groups (p ≥ 0.05). The 
average age of participants was 49.0 ± 7.35 years. The majority of participants were diagnosed 
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Table 1. Demographics and clinical characteristics
Parameter Exp. (n = 19) Cont. (n = 21) χ2 or t (p value)
Mean ± SD (range) or No. (%) Mean ± SD (range) or No. (%)
Age (years)* 49.95 ± 8.12 (34–67) 48.14 ± 6.67 (33–62)
≤ 39 1 (5.3) 2 (9.5) 2.280 (0.623)
40–49 9 (47.4) 10 (47.6)
50–59 7 (36.8) 9 (42.9)
≥ 60 2 (10.5) -
Marital status 0.007 (0.935)
Married 12 (63.2) 13 (61.9)
Single/widowed/divorced 7 (36.8) 8 (38.1)
Income (KRW) 0.973 (0.324)
< 3 million 12 (63.2) 10 (47.6)
≥ 3 million 7 (36.8) 11 (52.4)
Employment status 1.069 (0.301)
No 13 (68.4) 11 (52.4)
Yes 6 (31.6) 10 (47.6)
Religion 0.043 (0.836)
No 6 (31.6) 6 (28.6)
Yes 13 (38.4) 15 (71.4)
Economic burden 2.431 (0.119)
No 8 (42.1) 14 (66.3)
Yes 11 (57.9) 7 (33.4)
Education level 2.824 (0.093)
≤ High school 14 (73.7) 10 (47.6)
≥ College 5 (26.3) 11 (52.4)
Children* 0.302 (0.712)
No 5 (26.3) 4 (19.0)
Yes 14 (73.7) 17 (81.0)
Stage 1.269 (0.530)
I 4 (21.1) 7 (33.4)
II 10 (52.6) 11 (52.4)
III 5 (26.3) 3 (14.2)
Surgery type 0.935 (0.334)
Mastectomy 3 (31.6) 6 (28.6)
Breast conservation 16 (68.4) 15 (71.4)
Time since diagnosis (years)* 0.974 (0.674)
< 1 6 (31.6) 9 (42.9)
1–2 11 (57.9) 9 (42.9)
≥ 2 2 (10.5) 3 (14.2)
Chemotherapy* 1.905 (0.488)
None - 2 (9.5)
Completed 19 (100) 19 (90.5)
Radiation therapy* 1.778 (0.738)
None - 2 (9.5)
Completed 18 (94.7) 18 (85.7)
Currently 1 (5.3) 1 (4.8)
Endocrine therapy 0.082 (0.775)
No 10 (52.6) 12 (57.2)
Yes 9 (47.4) 9 (42.8)
Target therapy* 2.899 (0.217)
No 11 (57.9) 17 (81.0)
Yes 7 (36.8) 4 (19.0)
Unknown 1 (5.3) -
Triple-negative* 1.655 (0.525)
No 13 (68.4) 12 (57.1)
Yes 5 (26.3) 5 (23.8)
Unknown 1 (5.3) 4 (19.1)
Cont = control group; Exp = experimental group; SD = standard deviation; KRW = Korean Won.
*Fisher's exact test.
with either stage 1 or 2. More BCS had received breast conserving surgery than mastectomy. 
Most participants (85.8%–89.5%) had been diagnosed with BC within the last 2 years or 
less and had undergone not only chemotherapy but also radiation therapy. About half of the 
participants (45%) had undergone or were currently undergoing endocrine therapy (Table 1). 
The level of physical activity did not differ between the 2 groups at baseline [21].
Differences in physiological fatigue
As presented in Table 2, although there were no differences in IL-6 (t = 0.861, p = 0.397) and 
TNF-α (t = 1.698, p = 0.111) levels between the 2 groups at M1, overall IL-6 levels showed an 
increasing trend over time (also noted in Supplementary Figure 1), which was statistically 
significant (F = 9.881, p = 0.002). The IL-6 levels showed statistically meaningful time effects, 
with M4 time point levels increasing to higher levels than at M1 and M2 time points (F = 
9.492, p < 0.001). However, there was no significant group difference (F = 2.310, p = 0.148). 
There were no significant differences in TNF-α levels between groups (F = 1.039, p = 0.323) or 
between measurement time points (F = 1.475, p = 0.260). Regarding the effect of the BLESS 
program, there were no statistically significant differences in IL-6 (F = 1.157, p = 0.341) and 
TNF-α levels (F = 0.878, p = 0.436) between the experimental and control groups at M4. 
Further analysis of the changes in IL-6 and TNF-α levels in each group (Table 3) showed that 
IL-6 levels were elevated at M4 compared to M1 (p < 0.001) and M2 (p < 0.001) only in the 
experimental group, while TNF-α decreased at M4 compared to M1 (p = 0.042).
Differences in subjective fatigue
While a fatigue score of ≥ 4 out of 10 was an inclusion criterion, the mean total fatigue level 
of BCS at baseline was within moderate levels (5.35 experimental, 5.56 control) and did not 
differ between the groups (t = −0.374, p = 0.711). Subdomain fatigue scores at baseline did 
not differ either: behavioral/severity (t = −0.100, p = 0.921), affective meaning (t = −0.004, p 
= 0.997), sensory (t = −1.264, p = 0.214), and cognitive/mood (t = 0.014, p = 0.989). Regarding 
the effect of the BLESS program, the experimental group dropped to low (< 4) fatigue level 
immediately after the intervention (3.88 ± 0.32, p = 0.022) compared to the control group, 
which remained at moderate level (4.95 ± 0.31). The difference between the groups was 
statistically significant for fatigue level.
The total fatigue level showed statistically meaningful time effects, with levels decreasing across 
the time points (F = 9.492, p < 0.001). All of the following fatigue subdomain scores also showed 
time effects: behavioral/severity (F = 13.238, p < 0.001), affective meaning (F = 3.725, p < 0.05), 
sensory (F = 4.544, p < 0.01), and cognitive/mood (F = 5.949, p < 0.01) decreased over the time 
points. However, there were no significant differences in both total and subdomain fatigue 
scores when analyzed for group effects as well as for group-time effects (Table 4).
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Table 2. Parameter estimates of IL-6 and TNF-α levels
Parameter Time Exp. (n = 12) Cont. (n = 6) Sources F p value
Mean ± SE (95% CI) Mean ± SE (95% CI)
IL-6 (pg/mL) M1 14.11 ± 2.11 (9.63–18.59) 9.23 ± 2.99 (2.90–15.57) Group 2.310 0.148
M2 13.85 ± 2.16 (9.26–18.43) 9.18 ± 3.05 (2.71–15.65) Time 9.881 0.002
M4 18.23 ± 2.07 (13.83–22.62) 11.40 ± 2.93 (5.18–17.62) Group × Time 1.157 0.341
TNF-α (pg/mL) M1 78.40 ± 15.13 (46.33–110.47) 50.35 ± 21.39 (5.00–95.70) Group 1.039 0.323
M2 74.18 ± 14.92 (42.55–105.82) 50.07 ± 21.10 (5.33–94.81) Time 1.475 0.260
M4 60.73 ± 7.32 (45.21–76.26) 47.12 ± 10.36 (25.16–69.07) Group × Time 0.878 0.436
CI = confidence interval; Cont = control group; Exp = experimental group; IL-6= interleukin-6; M1 = baseline; M2 = post-intervention; M4 = after 6 months; SE = 
standard error; TNF-α = tumor necrosis factor-α.
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Table 4. Comparison of subjective fatigue levels
Parameter Time Exp. (n = 19) Cont. (n = 21) t p value Sources F p value
Mean ± SE (95% CI) Mean ± SE (95% CI)
Total M1 5.35 ± 0.41 (4.53–6.17) 5.56 ± 0.39 (4.78–6.33) −0.374 0.711 Group 1.784 0.189
M2 3.88 ± 0.32 (3.22–4.53) 4.95 ± 0.31 (4.32–5.57) −2.393 0.022 Time 9.492 < 0.001
M3 4.15 ± 0.41 (3.32–4.98) 4.33 ± 0.41 (3.51–5.16) −0.413 0.682 Group × Time 2.069 0.118
M4 3.68 ± 0.42 (2.87–4.53) 4.59 ± 0.41 (3.77–5.40) −1.415 0.166
Behavioral/severity M1 5.60 ± 0.46 (4.74–6.37) 5.66 ± 0.44 (4.68–6.24) −0.100 0.921 Group 0.920 0.344
M2 3.82 ± 0.43 (3.13–4.63) 5.12 ± 0.41 (4.30–5.74) −2.137 0.039 Time 13.238 < 0.001
M3 4.04 ± 0.50 (2.98–4.70) 4.24 ± 0.49 (3.46–4.87) −0.492 0.626 Group × Time 2.513 0.069
M4 3.70 ± 0.52 (2.87–4.69) 4.25 ± 0.50 (3.33–5.11) −0.652 0.519
Affective meaning M1 6.09 ± 0.57 (4.94–7.24) 6.10 ± 0.55 (5.01–7.19) −0.004 0.997 Group 0.627 0.433
M2 5.04 ± 0.47 (4.10–5.98) 5.86 ± 0.44 (4.96–6.75) −1.245 0.221 Time 3.725 0.018
M3 5.09 ± 0.55 (3.99–6.19) 5.17 ± 0.54 (4.08–6.26) −0.139 0.890 Group × Time 1.290 0.290
M4 4.41 ± 0.55 (3.30–5.52) 5.50 ± 0.53 (4.43–6.56) −1.234 0.226
Sensory M1 4.82 ± 0.53 (3.76–5.88) 5.70 ± 0.50 (4.69–6.71) −1.264 0.214 Group 3.557 0.067
M2 3.47 ± 0.45 (2.57–4.37) 4.87 ± 0.43 (4.01–5.73) −2.153 0.038 Time 4.544 0.007
M3 3.84 ± 0.55 (2.73–4.95) 4.36 ± 0.56 (3.23–5.48) −0.676 0.504 Group × Time 0.440 0.726
M4 3.30 ± 0.53 (2.23–4.37) 4.36 ± 0.51 (3.33–5.39) −1.400 0.171
Cognitive/mood M1 4.89 ± 0.44 (4.01–5.78) 4.89 ± 0.42 (4.05–5.72) 0.014 0.989 Group 0.903 0.348
M2 3.34 ± 0.37 (2.58–4.09) 4.08 ± 0.36 (3.36–4.79) −1.383 0.175 Time 5.949 0.002
M3 3.78 ± 0.46 (2.84–4.72) 3.79 ± 0.47 (2.84–4.74) −0.092 0.927 Group × Time 1.082 0.366
M4 3.36 ± 0.44 (2.48–4.25) 4.30 ± 0.42 (3.45–5.16) −1.398 0.171
CI = confidence interval; Cont = control group; Exp = experimental group; M1 = baseline; M2 = post-intervention; M3 = after 1 month; M4 = after 6 months; SE = 
standard error.
Table 3. Pairwise comparisons estimate of IL-6 and TNF-α levels (n = 18)
Group Time points Mean or mean difference SE p value 95% CI
Exp. + Cont. M1 IL-6 11.67 1.83 NA 15.55, 11.67
M2 IL-6 11.51 1.87 NA 15.48, 11.52
M4 IL-6 14.81 1.80 NA 18.62, 14.81
M1 TNF-α 64.38 13.10 NA 92.15, 64.38
M2 TNF-α 62.13 12.92 NA 89.52, 62.13
M4 TNF-α 53.93 6.34 NA 67.37, 53.93
Exp. IL-6 M1 M2 0.26 0.27 0.349 −0.31, 0.83
M4 −4.12 0.91 < 0.001 −6.05, −2.19
M2 M1 −0.26 0.27 0.349 −0.83, 0.31
M4 −4.38 0.85 < 0.001 −6.18, −2.57
M4 M1 4.12 0.91 < 0.001 2.19, 6.05
M2 4.38 0.85 < 0.001 2.57, 6.18
Cont. IL-6 M1 M2 0.05 0.38 0.897 −0.75, 0.85
M4 −2.17 1.29 0.112 −4.90, 0.56
M2 M1 −0.05 0.38 0.897 −0.85, 0.75
M4 −2.22 1.20 0.084 −4.77, 0.33
M4 M1 2.17 1.29 0.112 −0.56, 4.90
M2 2.22 1.20 0.084 −0.33, 4.77
Exp. TNF-α M1 M2 4.22 2.02 0.054 −0.07, 8.51
M4 17.67 7.98 0.042 0.74, 34.59
M2 M1 −4.22 2.02 0.054 −8.51, 0.07
M4 13.45 7.72 0.101 −2.91, 29.81
M4 M1 −17.67 7.98 0.042 −34.59, −0.74
M2 −13.45 7.72 0.101 −29.81, 2.91
Cont. TNF-α M1 M2 0.28 2.86 0.922 −5.78, 6.35
M4 3.23 11.29 0.778 −20.70, 27.17
M2 M1 −0.28 2.86 0.922 −6.35, 5.78
M4 2.95 10.92 0.790 −20.19, 26.09
M4 M1 −3.23 11.29 0.778 −27.17, 20.70
M2 −2.95 10.92 0.790 −26.09, 20.19
CI = confidence interval; Cont = control group; Exp = experimental group; IL-6= interleukin-6; M1 = baseline; M2 = post-intervention; M4 = after 6 months; NA = 
not applicable; SE = standard error; TNF-α = tumor necrosis factor-α.
Relationship between physiological and subjective fatigue
There was a significant strong positive correlation between IL-6 and TNF-α levels at M1, 
M2, and M4 (r = 0.658 to 0.992, p < 0.001). Subjective fatigue scores showed a significant 
moderate positive correlation at M1, M2, M3, and M4 (r = 0.444 to 0.694, p <0.001). However, 
there was no significant correlation between physiological and subjective fatigue at any of the 
time points (Table 5).
DISCUSSION
This study examined the effects of the BLESS exercise adherence program on CRF and 
physiological parameters (IL-6 and TNF-α levels) among BCS. The findings from this study 
indicate that subjective perception of fatigue decrease over time in BCS, while physiological 
factors had distinct patterns. In contrast to previous studies that lacked a theoretical 
framework to explain the relationship between pro-inflammatory markers, self-reported 
fatigue scores, and effects of exercise [12,13,17,24], this study used the NIH-SSM framework 
[18] for the characterization of biobehavioral symptoms [25]. Using this model, we 
characterized CRF as being the result of a complex interaction between symptoms and pro-
inflammatory cytokine levels according to the effects of the exercise program. Although the 
BLESS program did not lead to statistically significant improvement of physiological fatigue 
and there was a time effect of subjective fatigue decreasing overall, we found that subjective 
perception of fatigue decreased significantly in the experimental group at M2. As such, 
the theoretical basis for the usefulness of the NIH-SSM for CRF management in BCS was 
supported. The total fatigue mean score of BCS at baseline was at moderate level, ranging 
from 5.35 to 5.56 points, with a subsequent decrease in CRF over time. This baseline level 
is similar to the total fatigue mean score of 5.2 in a study using the R-PFS [22] with Spanish 
BCS within 2 years of BC diagnosis who had completed active treatment [26]. However, it is 
higher than the score of 3.83 in a study of Korean BCS 6 months to 2 years after completion 
of treatment [27], most likely because our study focused on recruiting BCS with greater than 
moderate CRF (≥ 4).
In several studies with BCS [4-7] exercise was a significant factor in improving fatigue, 
and a meta-analysis [8] showed that exercise interventions reduce CRF and brings short-
term improvements in physical functioning of BCS. In this analysis, total fatigue level of 
the experimental group was statistically significantly lowered immediately after the BLESS 
program. This is in agreement with the results of a previous study of Korean breast cancer 
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Table 5. Relationship between physiological and subjective fatigue
I (M1) I (M2) I (M4) T (M1) T (M2) T (M4) F (M1) F (M2) F (M3)
I (M1) -
I (M2) 0.819*
I (M4) 0.912* 0.921*
T (M1) 0.818* 0.733* 0.852*
T (M2) 0.658* 0.924* 0.835* 0.797*
T (M4) 0.952* 0.954* 0.866* 0.988* 0.992*
F (M1) −0.114 0.024 0.202 0.188 0.196 0.284
F (M2) −0.350 −0.274 −0.162 −0.206 −0.189 −0.164 0.575*
F (M3) −0.268 −0.223 0.122 −0.077 −0.100 −0.043 0.553* 0.694*
F (M4) −0.062 −0.021 0.215 0.257 0.242 0.295 0.498* 0.566* 0.444*
F = Korean version of revised Piper Fatigue Scale; I = interleukin-6; M1 = baseline; M2 = post-intervention; M3 = after 1 month; M4 = after 6 months; T = tumor 
necrosis factor-α.
*p < 0.001.
patients who completed chemotherapy [10]. Although this particular study reported that 
a 4-weeks exercise-based rehabilitation program reduced fatigue after 8 weeks, our study 
demonstrated that longer interventions that incorporate home-based exercise are feasible 
and effective for fatigue alleviation. The BLESS program was a feasible-program that 
provides accurate and safe exercise training designed by exercise professionals; starting with 
supervised exercise but transitioning to home-based exercise adherence.
The high participation rate of our study also suggests that BCS in the early survivorship 
stage who are experiencing fatigue may perhaps prefer exercise interventions that are 
longer in structure if they effectively engage participants. In the present study, the exercise 
participants' fatigue scores decreased over time, but moderate levels of CRF of 4 points or 
greater persisted in the control group. In the experimental group, both immediately after the 
exercise intervention and after 6 months, CRF was reduced to a mild level of 4 points or less, 
which has significance for clinical interpretation.
This study failed to find a significant relationship between physiological and subjective 
fatigue, which contrasts with Bower et al.'s [17] findings that IL-6 and TNF-α levels were 
associated with self-reported CRF over a period of 6 years after treatment (M = 4.3 years). 
Although it is possible our physiological measurement points may have not been optimal to 
sufficiently examine potential relationships between subjective and physiological fatigue, 
the mechanisms by which CRF occurs in cancer survivors are not yet fully explained. 
The prevailing consensus is that CRF is influenced by multidimensional factors such as 
physiological, psycho-emotional, and sociological factors [28]. The R-PFS tool used in this 
study is a self-reported fatigue assessment that is a multidimensional measure of the overall 
fatigue including behavioral/severity, affective meaning, sensory, and cognitive/mood aspects, 
whereas IL-6 and TNF-α measurement is an objective indicator that represents physiological 
mechanisms. Fatigue, like pain, is a subjective assessment of individual thresholds and 
strengths, so it should comprehensively cover mental, spiritual, and social fatigue as well 
as the physical fatigue experienced by patients. Another possible explanation is that our 
participants may have underestimated their fatigue level on self-report. In Korea, traditional 
Confucianism is deeply rooted, and many BCS struggle to continue to perform multiple 
family roles and bear the burden and stress of child rearing and living as a devoted mother and 
wife, which continues within the cancer trajectory. Even in the presence of extreme physical 
fatigue, it is possible that Korean BCS are less attuned to their level of fatigue due to the social 
constructs of  perseverance and endurance. Therefore, the association between measures 
of subjective and physiological fatigue should be carefully interpreted in light of the socio-
cultural context factors of BCS and explored further in future studies.
This study did not find significant group or group-time effects in IL-6 and TNF-α levels 
between the experimental and control groups. Our finding was consistent with reports 
of previous studies, which found no significant changes in IL-6, TNF-α, and other pro-
inflammatory cytokine levels between groups after an exercise intervention [13,16, 24]. In 
this study, however, there was a significant time effect of increasing IL-6 levels after 6 months 
compared to baseline, only in the experimental group, which supports the results of previous 
studies reporting that IL-6 levels show a long-term increase after moderate-intensity repeated 
exercise [12-14]. As elevation of pro-inflammatory cytokine levels is interpreted as an 
indicator of acute inflammation and can also reflect acute and chronic disease development 
and cancer prognosis [24,28], we should be careful in selecting pro-inflammatory cytokines 
for fatigue measurement.
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This study presents some limitations. Although participant selection bias was minimized by the 
randomized clinical trial (RCT) design, a small sample size was used. We were also unable to 
prevent a high drop-out rate in blood testing in the longitudinal follow-up. This was especially 
notable in the control group, although they were provided with standard exercise information 
and special activities during the follow-up period. Therefore, the effectiveness of exercise 
adherence interventions should be studied further with larger sample size RCTs. Another 
limitation is that sampling was not conducted at the same time (e.g., morning or afternoon), 
but performed when the participants could come for sampling. Future studies should explore 
potential seasonal effects in pro-inflammatory cytokine levels by minimizing circadian changes 
through blood sampling at the same time of day, including all 4 seasons. In addition, although 
the BLESS program trained participants using light, moderate, and high-intensity exercises 
in addition to providing video clips, the home-based exercise was based on self-report, and 
exercise adherence according to exercise intensity could not be verified in detail.
Despite these limitations, this study was unique in that BCS already experiencing fatigue, 
a known barrier to practicing exercise, were recruited and successfully engaged over 12 
weeks, with significant reduction in subjective fatigue at post-intervention. A strength of this 
study was that light, moderate, and vigorous intensity exercises tailored to BCS limitations 
and needs were developed and video clips were provided. However, a variety of creative 
multidisciplinary patient-centered exercise programs are in demand, so patients can adhere 
to exercise without time and space restrictions in a self-care context. Future studies could 
benefit from using augmented reality or virtual reality, after familiarization with the exercise 
program with an expert trainer. Also, this study employed a longitudinal design to evaluate 
the effects of exercise in CRF, reflecting both physiological and subjective fatigue, which had 
not been possible in previous cross-sectional studies.
SUPPLEMENTARY MATERIAL
Supplementary Figure 1
Pattern of physiological and subjective fatigue level according to time points. (A) Subjective 
fatigue over time in the experimental and control groups. (B) Interleukin-6 in the 
experimental and control groups across three measurement points. (C) Tumor necrosis 
factor-α in the experimental and control groups across three measurement points.
Click here to view
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